|
Coproporphyria, Hereditary
|
C18.452.811.400.074 |
|
|
Presynaptic Terminals
|
D017729 |
[The distal terminations of axons which are specialized for the release of neurotransmitters. Also included are varicosities along the course of axons which have similar specializations and also release transmitters. Presynaptic terminals in both the central and peripheral nervous systems are included.
] |
|
Saccharomyces boulardii
|
D000069983 |
[A species of Saccharomyces that is used as a PROBIOTIC, such as in the treatment of DIARRHEA and PSEUDOMEMBRANOUS ENTEROCOLITIS associated with CLOSTRIDIUM INFECTIONS.
] |
|
Molecular Epidemiology
|
D017720 |
[The application of molecular biology to the answering of epidemiological questions. The examination of patterns of changes in DNA to implicate particular carcinogens and the use of molecular markers to predict which individuals are at highest risk for a disease are common examples.
, The epidemiological evaluation of the role of inherited causes of disease in families and in populations; it aims to detect the inheritance pattern of a particular disease, localize the gene and find a marker associated with disease susceptibility. Gene-gene and gene-environment interactions are also studied in genetic epidemiology of a disease. In its broad context, genetic epidemiology includes family studies, molecular epidemiologic studies with genetic components, and more traditional cohort and case-control studies with family history components.
] |
|
Argas
|
B01.050.500.131.166.132.832.100.100 |
|
|
Argasidae
|
B01.050.500.131.166.132.832.100 |
|
|
Bifidobacterium animalis
|
D000069982 |
[A species of Bifidobacterium that occurs in the LARGE INTESTINE of humans and other mammals and in FERMENTED DAIRY PRODUCTS. It is used as a PROBIOTIC.
] |
|
Mice, Inbred SENCAR
|
B01.050.050.199.520.520.600 |
|
|
Mice, Inbred Strains
|
B01.050.050.199.520.520 |
|
|
Bifidobacterium bifidum
|
D000069985 |
[A species of Bifidobacterium that occurs in the human GASTROINTESTINAL TRACT, especially in infants, and in FERMENTED DAIRY PRODUCTS. It produces BACTERIOCINS and is used as a PROBIOTIC.
] |
|
Bifidobacterium breve
|
D000069984 |
[A species of Bifidobacterium present in the human GUT MICROBIOTA. It is used as a PROBIOTIC.
] |
|
Time
|
G01.910 |
|
|
Neural Analyzers
|
A08.675.575 |
|
|
Drug Overdose
|
E02.319.306.500.500 |
|
|
Prescription Drug Misuse
|
E02.319.306.500 |
|
|
Drug Utilization Review
|
D017723 |
[Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for Medicaid programs beginning in 1993.
] |
|
Early Growth Response Protein 1
|
D12.776.460.525.500 |
|
|
Escherichia coli O104
|
D000069981 |
[An enterohemorrhagic Escherichia coli of the O subfamily that can cause severe FOODBORNE DISEASE. The H4 serotype strain produces SHIGA TOXINS and has been linked to human disease outbreaks, including some cases of HEMOLYTIC-UREMIC SYNDROME, resulting from contamination of foods by feces containing E. coli O104.
] |
|
Hospital Charges
|
D017722 |
[The prices a hospital sets for its services. HOSPITAL COSTS (the direct and indirect expenses incurred by the hospital in providing the services) are one factor in the determination of hospital charges. Other factors may include, for example, profits, competition, and the necessity of recouping the costs of uncompensated care.
] |
|
Furazolidone
|
D03.383.312.649.313 |
|